Last deal

$7.5M

Amount

Series A

Stage

12.06.2024

Date

3

all rounds

$16.61M

Total amount

date founded

Financing round

General

About Company
Alida Biosciences develops RNA analysis tools to improve human health.

Industry

Sector :

Subsector :

Also Known As

AlidaBio

founded date

01.01.2020

Number of employees

Company Type

For Profit

Last funding type

Series A

IPO status

Private

Description

Founded in 2020 and located in San Diego, CA, Alida Biosciences is an epigenetics company that creates new technologies in RNA biology to improve human health. Their tools enable patients to receive better medical treatments and diagnostic assays. The company is focused on developing the next generation of RNA analysis tools to enable new medical treatments and diagnostic assays.
Contacts

Contact Email

Phone number

Social url

Legal Names

Legal name

Alida Biosciences, Inc.
Similar Companies
999
Compendia Bioscience

Compendia Bioscience

Compendia Bioscience uses cancer genomic data to improve patient treatment.

Sector

Pharmaceuticals and Biotechnology

Subsector

Biotechnology

Location

Ann Arbor, MI, USA

total rounds

1
Prometheus Biosciences

Prometheus Biosciences

Prometheus Biosciences develops precision therapeutics and diagnostics for IBD.

Sector

Pharmaceuticals and Biotechnology

Subsector

Biotechnology

Keywords

Biotechnology, Health Care, Medical

Location

San Diego, CA, USA

total rounds

6

total raised

$951.84M
Oxford Biodynamics

Oxford Biodynamics

Oxford BioDynamics develops tools for early cancer and genetic disease detection.

Sector

Pharmaceuticals and Biotechnology

Subsector

Biotechnology

Location

Oxford, UK

total rounds

5

total raised

$42.51M
Swift Biosciences

Swift Biosciences

Swift Biosciences develops and commercializes NGS Library Preparation Kits that expand the applications of next-generation sequencing.

Sector

Pharmaceuticals and Biotechnology

Subsector

Biotechnology

Location

Ann Arbor, MI, USA

total rounds

7

total raised

$31.2M

Financials

Funding Rounds
5
3

Number of Funding Rounds

$16.61M

Money Raised

Their latest funding was raised on 12.06.2024. Their latest investor National Human Genome Research Institute. Their latest round Series A

Date 
Funding Round 
Investors 
Money Raised 
Lead 
12.06.2024
3
$7.5M
11.05.2022
$4M
Genoa Ventures

Genoa Ventures

Genoa Ventures invests in early-stage life sciences technology companies.

Sector

General Industrials

Subsector

Diversified Industrials

Keywords

Biotechnology, Venture Capital, Life Science

Location

San Francisco, CA, USA

count Of Investments

28

count Of Exists

2
National Human Genome Research Institute

National Human Genome Research Institute

The National Human Genome Research Institute (NHGRI) is leading genomics research at the National Institutes of Health (NIH).

Sector

Pharmaceuticals and Biotechnology

Subsector

Biotechnology

Location

Bethesda, MD, USA

count Of Investments

13

count Of Exists

1
Co-Investors
Investors
4
2

Number of lead investors

4

Number of investors

Investor 
Lead 
Round 
Partners 
National Human Genome Research Institute

National Human Genome Research Institute

The National Human Genome Research Institute (NHGRI) is leading genomics research at the National Institutes of Health (NIH).

Sector

Pharmaceuticals and Biotechnology

Subsector

Biotechnology

Location

Bethesda, MD, USA

count Of Investments

13

count Of Exists

1
FusionX Ventures

FusionX Ventures

FusionX Ventures is a venture capital firm that invests in early-stage startups focused on building cloud-enabled Smart Machines.

Sector

General Industrials

Subsector

Diversified Industrials

Location

San Diego, CA, USA

count Of Investments

16
Genoa Ventures

Genoa Ventures

Genoa Ventures invests in early-stage life sciences technology companies.

Sector

General Industrials

Subsector

Diversified Industrials

Keywords

Biotechnology, Venture Capital, Life Science

Location

San Francisco, CA, USA

count Of Investments

28

count Of Exists

2

People

Employee Profiles
1

Gudrun Stengel

CEO & Founder

Activity

Recent News
1